Eton Pharmaceuticals (ETON) Non-Current Debt (2019 - 2026)
Eton Pharmaceuticals (ETON) posted Non-Current Debt of $21.8 million for Q4 2025, down 21.1% sequentially from $27.6 million in Q3 2025, and down 26.98% YoY from $29.8 million in Q4 2024.
Eton Pharmaceuticals (ETON) Non-Current Debt (2019 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Non-Current Debt for 7 years, with the latest figure at $21.8 million in Q4 2025.
- Quarterly Non-Current Debt fell 26.98% year-over-year to $21.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.8 million (down 26.98% YoY) and the FY2025 annual result came in at $21.8 million, down 26.98% from the prior year.
- Non-Current Debt eased to $21.8 million in Q4 2025 per ETON's latest filing, from $27.6 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $30.0 million in Q1 2025 and troughed at $4.2 million in Q3 2023.
- A 5-year average of $12.3 million and a median of $5.9 million in 2021 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2021 and 2025: Non-Current Debt soared 35.3% in 2021, then decreased 26.98% in 2025.
- Over 5 years, Non-Current Debt stood at $5.3 million in 2021, then rose by 2.32% to $5.4 million in 2022, then retreated by 22.05% to $4.2 million in 2023, then jumped by 610.29% to $29.8 million in 2024, then declined by 26.98% to $21.8 million in 2025.
- According to Business Quant data, Non-Current Debt over the past three periods registered $21.8 million, $27.6 million, and $27.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 130.00 Mn |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | 19.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.08 Mn |
| Dec 31, 2025 | 21.77 Mn |
| Sep 30, 2025 | 27.59 Mn |
| Jun 30, 2025 | 27.41 Mn |
| Mar 31, 2025 | 29.99 Mn |
| Dec 31, 2024 | 29.81 Mn |
| Sep 30, 2023 | 4.20 Mn |
| Jun 30, 2023 | 4.55 Mn |
| Mar 31, 2023 | 5.11 Mn |
| Dec 31, 2022 | 5.38 Mn |
| Sep 30, 2022 | 5.68 Mn |
| Jun 30, 2022 | 5.99 Mn |
| Mar 31, 2022 | 6.33 Mn |
| Dec 31, 2021 | 5.26 Mn |
| Sep 30, 2021 | 5.55 Mn |
| Jun 30, 2021 | 5.86 Mn |
| Mar 31, 2021 | 6.18 Mn |
| Dec 31, 2020 | 6.53 Mn |
| Sep 30, 2020 | 6.50 Mn |
| Jun 30, 2020 | 4.59 Mn |